C07C 311/58
Having nitrogen atoms of the sulfonylurea groups bound to hydrogen atoms or
Official title: having nitrogen atoms of the sulfonylurea groups bound to hydrogen atoms or to acyclic carbon atoms
C07C311/58 (Having nitrogen atoms of the sulfonylurea groups bound to hydrogen atoms or) appears on 102 US grants and 64 published applications in this corpus.
Search patents in C07C- Granted patents
- 102
- Published applications
- 64
- Assignees
- 47
- Inventors
- 206
- Latest grant
- 5 May 2026
Filings by year
| Year | Granted patents | Published applications |
|---|---|---|
| 1976 | 2 | 0 |
| 1977 | 2 | 0 |
| 1978 | 1 | 0 |
| 1979 | 0 | 0 |
| 1980 | 0 | 0 |
| 1981 | 1 | 0 |
| 1982 | 1 | 0 |
| 1983 | 0 | 0 |
| 1984 | 0 | 0 |
| 1985 | 0 | 0 |
| 1986 | 1 | 0 |
| 1987 | 0 | 0 |
| 1988 | 0 | 0 |
| 1989 | 0 | 0 |
| 1990 | 0 | 0 |
| 1991 | 0 | 0 |
| 1992 | 0 | 0 |
| 1993 | 3 | 0 |
| 1994 | 2 | 0 |
| 1995 | 4 | 0 |
| 1996 | 3 | 0 |
| 1997 | 8 | 0 |
| 1998 | 2 | 0 |
| 1999 | 2 | 0 |
| 2000 | 3 | 0 |
| 2001 | 1 | 0 |
| 2002 | 18 | 9 |
| 2003 | 5 | 13 |
| 2004 | 13 | 4 |
| 2005 | 1 | 0 |
| 2006 | 1 | 2 |
| 2007 | 0 | 2 |
| 2008 | 4 | 4 |
| 2009 | 1 | 2 |
| 2010 | 0 | 1 |
| 2011 | 1 | 0 |
| 2012 | 2 | 1 |
| 2013 | 1 | 1 |
| 2014 | 0 | 1 |
| 2015 | 1 | 2 |
| 2016 | 2 | 5 |
| 2017 | 4 | 3 |
| 2018 | 3 | 2 |
| 2019 | 1 | 1 |
| 2020 | 0 | 1 |
| 2021 | 1 | 2 |
| 2022 | 0 | 0 |
| 2023 | 3 | 4 |
| 2024 | 2 | 2 |
| 2025 | 1 | 0 |
| 2026 | 1 | 2 |
By publication year. Applications have been published since 2001. 2026 runs to 8 Oct.
Recent patents
- N-phenyl-3-mercaptopropanamide derivatives as metallo-beta-lactamase inhibitors for the treatment of bacterial infections5 May 2026US 12,616,670 B2Helmholtz-Zentrum FüR Infektionsforschung GmbH
- Protoporphyrinogen oxidase inhibitors20 May 2025US 12,302,900 B2Enko Chem, Inc.
- Chemical foaming agents containing tosyl groups31 Dec 2024US 12,183,479 B2Dow Global Technologies LLC
- Protoporphyrinogen oxidase inhibitors6 Feb 2024US 11,889,833 B2Enko Chem, Inc.
- Modulators of Mas-related G-protein receptor X4 and related products and methods12 Dec 2023US 11,840,521 B2Escient Pharmaceuticals, Inc.
- Modulators of mas-related g-protein receptor x4 and related products and methods23 Apr 2026US 2026/0108482 A1Escient Pharmaceuticals, Inc.
- Protoporphyrinogen oxidase inhibitors12 Mar 2026US 2026/0068883 A1Enko Chem, Inc.
- Modulators of mas-related g-protein receptor x4 and related products and methods12 Sep 2024US 2024/0300907 A1Escient Pharmaceuticals, Inc.
- Protoporphyrinogen oxidase inhibitors25 Apr 2024US 2024/0130365 A1Enko Chem, Inc.
- Protoporphyrinogen oxidase inhibitors9 Nov 2023US 2023/0354809 A1Enko Chem, Inc.
Most cited
By later US patents
- Amino acid derivative anticonvulsant44US 5,378,729 AResearch Corporation Technologies, Inc. · 1995
- Amino acid derivative anticonvulsant44US 5,654,301 AResearch Corporation Technologies, Inc. · 1997
- Sulfur substituted sulfonylaminocarboxylic acid N-arylamides, their preparation, their use and pharmaceutical preparations comprising them27US 6,335,334 B12002
- Tyrosine derivatives24US 6,469,047 B1Genentech, Inc. · 2002
- Substituted cinnamic, acid guanidides, process for their preparation, their use as a medicament, and medicament comprising them22US 6,399,824 B1Aventis Pharma Deutschland GmbH · 2002